Results 21 to 30 of about 2,213,888 (211)

Fluconazole resistance in Candida glabrata [PDF]

Antimicrobial Agents and Chemotherapy, 1993
We report a case of infection with Candida glabrata in which the organism became resistant to fluconazole and in which pre- and posttreatment isolates were available for comparison. The organism was cross-resistant to ketoconazole and itraconazole, in common with other azole-resistant yeasts.
C A, Hitchcock, G W, Pye, P F, Troke, E M, Johnson, D W, Warnock   +4 more
openaire   +2 more sources

Synergistic Effects of Amiodarone and Fluconazole on Candida tropicalis Resistant to Fluconazole [PDF]

Antimicrobial Agents and Chemotherapy, 2013
ABSTRACT There have recently been significant increases in the prevalence of systemic invasive fungal infections. However, the number of antifungal drugs on the market is limited in comparison to the number of available antibacterial drugs. This fact, coupled with the increased frequency of cross-resistance, makes it necessary to
Cecília Rocha, da Silva, João Batista, de Andrade Neto, José Júlio Costa, Sidrim, Maria Rozzelê Ferreira, Angelo, Hemerson Iury Ferreira, Magalhães, Bruno Coêlho, Cavalcanti, Raimunda Sâmia Nogueira, Brilhante, Danielle Silveira, Macedo, Manoel Odorico, de Moraes, Marina Duarte Pinto, Lobo, Thalles Barbosa, Grangeiro, Hélio Vitoriano, Nobre Júnior   +11 more
openaire   +2 more sources

Fluconazole Assists Berberine To Kill Fluconazole-Resistant Candida albicans [PDF]

Antimicrobial Agents and Chemotherapy, 2013
ABSTRACT It was found in our previous study that berberine (BBR) and fluconazole (FLC) used concomitantly exhibited a synergism against FLC-resistant Candida albicans in vitro . The aim of the present study was to clarify how BBR and FLC worked synergistically and the underlying mechanism ...
De-Dong, Li, Yi, Xu, Da-Zhi, Zhang, Hua, Quan, Eleftherios, Mylonakis, Dan-Dan, Hu, Ming-Bang, Li, Lan-Xue, Zhao, Liang-Hua, Zhu, Yan, Wang, Yuan-Ying, Jiang   +10 more
openaire   +2 more sources

Candida norvegensis: a fluconazole-resistant species [PDF]

Antimicrobial Agents and Chemotherapy, 1997
Candida norvegensis has been an unusual cause of infections in humans. In Norway this species was isolated from eight patients from 1990 to 1996 and was of probable pathogenic significance in four of them. All isolates were resistant to fluconazole. The same was true for two C. norvegensis isolates from before 1940, and it is therefore assumed that the
P, Sandven, K, Nilsen, A, Digranes, T, Tjade, J, Lassen   +4 more
openaire   +2 more sources

The resistance to fluconazole in patients with esophageal candidiasis [PDF]

Arquivos de Gastroenterologia, 2009
CONTEXT: Esophageal candidiasis is often observed in patients with risk factors for its development and fluconazole is the therapeutic choice for the treatment of this disease. OBJECTIVES: To determine its frequency, by performing upper digestive endoscopy; to determine Candida species involved in its pathogenesis and verify their distribution ...
Wilheim, Ana Botler, Miranda-Filho, Demócrito de Barros, Nogueira, Rodrigo Albuquerque, Rêgo, Rossana Sette de Melo, Lima, Kedma de Magalhães, Pereira, Leila Maria Moreira Beltrão   +5 more
openaire   +4 more sources

The assessment of therapeutic response of oropharyngeal and oesophageal candidiasis in AIDS using a new scoring system: studies with D0870. [PDF]

, 1999
We developed and compared five scoring systems designed to quantitate therapeutic response in cases of oropharyngeal candidiasis. We utilized prospectively collected data on 114 patients treated with several doses of the azole D0870.
Williams, Keith, Percy, Meryl, Atkinson, Gill, Denning, David W., Hollis, Sally, Hood, Stephen V.   +5 more
core   +4 more sources

Risk Factors for Fluconazole-Resistant Candidemia [PDF]

Antimicrobial Agents and Chemotherapy, 2010
ABSTRACT Previous studies have sought to determine the risk factors associated with candidemia caused by non- albicans Candida spp. or with potentially fluconazole-resistant Candida spp. ( C. glabrata and C. krusei ).
José, Garnacho-Montero, Ana, Díaz-Martín, Emilio, García-Cabrera, Maite, Ruiz Pérez de Pipaón, Clara, Hernández-Caballero, Javier, Aznar-Martín, José M, Cisneros, Carlos, Ortiz-Leyba   +7 more
openaire   +2 more sources

Fluconazole-resistant Candida parapsilosis: A new emerging threat in the fungi arena

Frontiers in Fungal Biology, 2022
Candida parapsilosis is a leading cause of invasive candidiasis in southern Europe, Latin America and Asia. C. parapsilosis has been mostly considered susceptible to triazoles, but fluconazole resistance is on the rise in some countries.
Pilar Escribano, Pilar Escribano, Jesús Guinea, Jesús Guinea, Jesús Guinea   +4 more
doaj   +1 more source

Successful Treatment of Fluconazole-Resistant Oropharyngeal Candidiasis by a Combination of Fluconazole and Terbinafine [PDF]

Clinical Diagnostic Laboratory Immunology, 1999
ABSTRACT Increasing incidence of resistance to conventional antifungal therapy has demanded that novel therapies be introduced. Recent in vitro studies have shown that combinations involving azoles and allylamines may be effective in inhibiting fluconazole-resistant fungi.
M A, Ghannoum, B, Elewski
openaire   +2 more sources

Biofilm formation by fluconazole-resistant Candida albicans strains is inhibited by fluconazole [PDF]

Journal of Antimicrobial Chemotherapy, 2007
The fungal pathogen Candida albicans forms biofilms on implanted medical devices, resulting in infections with high mortality. Fully developed biofilms, which are adherent communities of microorganisms, characteristically exhibit high resistance to antimicrobial drugs, making treatment of device-associated infection problematic.
Igor, Bruzual, Perry, Riggle, Susan, Hadley, Carol A, Kumamoto   +3 more
openaire   +2 more sources